** AbCellera Biologics Inc's shares ABCL.O up 4.7% at
$10.61 premarket
** ABCL has entered into collaboration with AbbVie Inc
ABBV.N to advance new antibody therapies urn:newsml:reuters.com:*:nBw17m0zHa
** Under the agreement, ABBV has the right to develop and
commercialize therapeutic antibodies resulting from the
collaboration
** ABCL will receive research payments and is eligible to
receive downstream clinical and commercial milestone payments
and royalties on net sales of products
** Up to Wednesday's close, stock had fallen ~29% YTD
(Reporting by Khushi Mandowara)
((Khushi.Mandowara@thomsonreuters.com;))